Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$9.57 USD
+0.07 (0.74%)
Updated May 17, 2024 04:00 PM ET
After-Market: $9.58 +0.01 (0.10%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.08 | -9.56% |
Earnings Summary
For their last quarter, Amicus Therapeutics (FOLD) reported earnings of -$0.02 per share, beating the Zacks Consensus Estimate of $-0.06 per share. This reflects a positive earnings surprise of 66.67%. Look out for FOLD's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.08 per share, reflecting a year-over-year increase of 46.67%.
Earnings History
Price & Consensus
Zacks News for FOLD
Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
FOLD: What are Zacks experts saying now?
Zacks Private Portfolio Services